"We have 10 years of supervised patient use." Yet other physicans urged the FDA committee to consider the lack of clinical evidence
The Future of Brain Health The landscape of neurocognitive health is evolving rapidly
(2018, Current Pharmaceutical Design) published a broad review of BPC-157's mechanisms and found consistent anti-inflammatory effects in rat models of inflammatory bowel disease, wound healing, and organ damage
GHK-Cu (sister peptide) given by intraperitoneal injection at 0.2/2/20 micrograms/g in mice reduced pulmonary fibrosis via Nrf2/NF-kB/TGF-beta1-Smad2/3 demonstrates systemic-injection dosing of the copper-tripeptide class in animals, relevant to the injectable question but GHK-Cu, lung, mouse
These treatments were followed by 30 days of nattokinase, at 100 mg/2,000 FUs daily
This reagent is a systemic form of RUO lyophilized reconstitution vial intended for laboratory testing and NOT a cosmetic product or drug